Sensei Biotherapeutics, Inc. · NASDAQ:SNSE

Stempoint Capital LP reported a 9.90% stake in Sensei Biotherapeutics, Inc. (Schedule 13G)

Event Mar 31, 2026 · Filed May 15, 2026

Stempoint Capital LP reported a 9.90% stake in Sensei Biotherapeutics, Inc., 132,873 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G).

Stake
9.90%
Shares
132,873
Intent
Passive
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
StemPoint Capital LP9.90%132,873
StemPoint Capital Management GP LLC9.90%132,873
Michelle Ross9.90%132,873

Source

View original at SEC

Related